These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11414359)

  • 1. The supportive role of complement in HIV pathogenesis.
    Stoiber H; Kacani L; Speth C; Würzner R; Dierich MP
    Immunol Rev; 2001 Apr; 180():168-76. PubMed ID: 11414359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of complement in the control of HIV dynamics and pathogenesis.
    Stoiber H; Speth C; Dierich MP
    Vaccine; 2003 Jun; 21 Suppl 2():S77-82. PubMed ID: 12763687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-HIV interactions during all steps of viral pathogenesis.
    Stoiber H; Banki Z; Wilflingseder D; Dierich MP
    Vaccine; 2008 Jun; 26(24):3046-54. PubMed ID: 18191309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection.
    Crowe SM
    Aust N Z J Med; 1995 Dec; 25(6):777-83. PubMed ID: 8770353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
    Luo S; Dasari P; Reiher N; Hartmann A; Jacksch S; Wende E; Barz D; Niemiec MJ; Jacobsen I; Beyersdorf N; Hünig T; Klos A; Skerka C; Zipfel PF
    Mol Immunol; 2018 Jan; 93():266-277. PubMed ID: 28860090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement in different stages of HIV infection and pathogenesis.
    Speth C; Stoiber H; Dierich MP
    Int Arch Allergy Immunol; 2003 Apr; 130(4):247-57. PubMed ID: 12740525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV and complement: hijacking an immune defense.
    Datta PK; Rappaport J
    Biomed Pharmacother; 2006 Nov; 60(9):561-8. PubMed ID: 16978830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement receptors in HIV infection.
    Doepper S; Kacani L; Falkensammer B; Dierich MP; Stoiber H
    Curr Mol Med; 2002 Dec; 2(8):703-11. PubMed ID: 12462391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV's other immune-system targets: macrophages.
    Balter M
    Science; 1996 Nov; 274(5292):1464-5. PubMed ID: 8966614
    [No Abstract]   [Full Text] [Related]  

  • 10. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
    Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
    J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mannose-binding lectin in the innate defense against Candida albicans: enhancement of complement activation, but lack of opsonic function, in phagocytosis by human dendritic cells.
    Ip WK; Lau YL
    J Infect Dis; 2004 Aug; 190(3):632-40. PubMed ID: 15243942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders.
    Cassone A; Cauda R
    AIDS; 2012 Jul; 26(12):1457-72. PubMed ID: 22472853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative complement pathway activation by CD4+ T cells of HIV infected individuals: a possible role in AIDS pathogenesis.
    Yefenof E; Magyarlaki T; Fenyo EM; Wahren B; Klein E
    Int Immunol; 1994 Sep; 6(9):1361-6. PubMed ID: 7819144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The complement system as a mediator of acute inflammation].
    Müller-Peddinghaus R
    Dtsch Tierarztl Wochenschr; 1983 Sep; 90(9):374-7. PubMed ID: 6354683
    [No Abstract]   [Full Text] [Related]  

  • 15. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K; Sacks SH; Sheerin NS
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered CD4+ T cell phenotype and function determine the susceptibility to mucosal candidiasis in transgenic mice expressing HIV-1.
    Lewandowski D; Marquis M; Aumont F; Lussier-Morin AC; Raymond M; Sénéchal S; Hanna Z; Jolicoeur P; de Repentigny L
    J Immunol; 2006 Jul; 177(1):479-91. PubMed ID: 16785545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of campylobacter species with antibody, complement and phagocytes.
    Bernatowska E; Jose P; Davies H; Stephenson M; Webster D
    Gut; 1989 Jul; 30(7):906-11. PubMed ID: 2788111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells.
    Pruenster M; Wilflingseder D; Bánki Z; Ammann CG; Muellauer B; Meyer M; Speth C; Dierich MP; Stoiber H
    Eur J Immunol; 2005 Sep; 35(9):2691-8. PubMed ID: 16094691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.
    Zaragoza O; Casadevall A
    Cell Microbiol; 2006 Dec; 8(12):1862-76. PubMed ID: 16824038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis.
    Poluektova LY; Munn DH; Persidsky Y; Gendelman HE
    J Immunol; 2002 Apr; 168(8):3941-9. PubMed ID: 11937550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.